These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 25476893)
1. PBI-05204, a supercritical CO₂ extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway. Pan Y; Rhea P; Tan L; Cartwright C; Lee HJ; Ravoori MK; Addington C; Gagea M; Kundra V; Kim SJ; Newman RA; Yang P Invest New Drugs; 2015 Apr; 33(2):271-9. PubMed ID: 25476893 [TBL] [Abstract][Full Text] [Related]
2. Response to: Does the Nerium oleander extract PBI-05204 have potential for pancreatic cancer? Newman RA; Yang P Invest New Drugs; 2015 Jun; 33(3):788-9. PubMed ID: 25597755 [No Abstract] [Full Text] [Related]
3. Does the Nerium oleander extract PBI-05204 have potential for pancreatic cancer therapy? Calderón-Montaño JM; Burgos-Morón E; Guillén-Mancina E; López-Lázaro M Invest New Drugs; 2015 Jun; 33(3):787. PubMed ID: 25698441 [No Abstract] [Full Text] [Related]
4. Mechanism of metformin enhancing the sensitivity of human pancreatic cancer cells to gem-citabine by regulating the PI3K/Akt/mTOR signaling pathway. Zhou HY; Yao XM; Chen XD; Tang JM; Qiao ZG; Wu XY Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10283-10289. PubMed ID: 31841183 [TBL] [Abstract][Full Text] [Related]
5. The Botanical Drug PBI-05204, a Supercritical CO Colapietro A; Yang P; Rossetti A; Mancini A; Vitale F; Martellucci S; Conway TL; Chakraborty S; Marampon F; Mattei V; Gravina GL; Biordi AL; Wei D; Newman RA; Festuccia C Front Pharmacol; 2020; 11():552428. PubMed ID: 33013390 [TBL] [Abstract][Full Text] [Related]
6. First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors. Hong DS; Henary H; Falchook GS; Naing A; Fu S; Moulder S; Wheler JJ; Tsimberidou A; Durand JB; Khan R; Yang P; Johansen M; Newman RA; Kurzrock R Invest New Drugs; 2014 Dec; 32(6):1204-12. PubMed ID: 24919855 [TBL] [Abstract][Full Text] [Related]
7. Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer. Mu GG; Zhang LL; Li HY; Liao Y; Yu HG Dig Dis Sci; 2015 Apr; 60(4):1067-80. PubMed ID: 25344906 [TBL] [Abstract][Full Text] [Related]
8. Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipid-soluble cardiac glycoside. Newman RA; Kondo Y; Yokoyama T; Dixon S; Cartwright C; Chan D; Johansen M; Yang P Integr Cancer Ther; 2007 Dec; 6(4):354-64. PubMed ID: 18048883 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo neuroprotective activity of the cardiac glycoside oleandrin from Nerium oleander in brain slice-based stroke models. Dunn DE; He DN; Yang P; Johansen M; Newman RA; Lo DC J Neurochem; 2011 Nov; 119(4):805-14. PubMed ID: 21950737 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of canagliflozin on pancreatic cancer are mediated via the downregulation of glucose transporter‑1 and lactate dehydrogenase A. Xu D; Zhou Y; Xie X; He L; Ding J; Pang S; Shen B; Zhou C Int J Oncol; 2020 Nov; 57(5):1223-1233. PubMed ID: 32901837 [TBL] [Abstract][Full Text] [Related]
11. Targeting Pancreatic Cancer with Novel Nicolaioidesin C Derivatives: Molecular Mechanism, Yamazaki T; Phan ND; Maneenet J; Yamagishi M; Nishikawa Y; Okada T; Okumura T; Toyooka N; Fujii T; Awale S J Med Chem; 2024 Aug; 67(16):14313-14328. PubMed ID: 39106150 [TBL] [Abstract][Full Text] [Related]
12. CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis. Subramaniam D; Periyasamy G; Ponnurangam S; Chakrabarti D; Sugumar A; Padigaru M; Weir SJ; Balakrishnan A; Sharma S; Anant S Mol Cancer Ther; 2012 Jul; 11(7):1598-608. PubMed ID: 22532602 [TBL] [Abstract][Full Text] [Related]
13. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy. Song J; Xu J; Guo J; Shang Y; Wang J; Wang T Acta Histochem; 2021 Sep; 123(6):151769. PubMed ID: 34416437 [TBL] [Abstract][Full Text] [Related]
14. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation. Zhu J; Lv J; Chen J; Zhang X; Ji Y Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959 [No Abstract] [Full Text] [Related]
15. Efficacy of oleandrin and PBI-05204 against bovine viruses of importance to commercial cattle health. Newman RA; Chase CCL; Matos JR; Abdelsalam K; Buterbaugh R; Van Holland S; Abdelaal H; Woolum A; Jagannadha Sastry K Antivir Chem Chemother; 2022; 30():20402066221103960. PubMed ID: 35611441 [TBL] [Abstract][Full Text] [Related]
16. PBI-05204, a supercritical CO Chakraborty S; Wei D; Tran M; Lang FF; Newman RA; Yang P Neoplasia; 2024 Aug; 54():101008. PubMed ID: 38823209 [TBL] [Abstract][Full Text] [Related]
17. The Botanical Drug PBI-05204, a Supercritical CO Colapietro A; Yang P; Rossetti A; Mancini A; Vitale F; Chakraborty S; Martellucci S; Marampon F; Mattei V; Gravina GL; Iorio R; Newman RA; Festuccia C Front Pharmacol; 2022; 13():852941. PubMed ID: 35401175 [TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2. Plante KS; Dwivedi V; Plante JA; Fernandez D; Mirchandani D; Bopp N; Aguilar PV; Park JG; Tamayo PP; Delgado J; Shivanna V; Torrelles JB; Martinez-Sobrido L; Matos R; Weaver SC; Sastry KJ; Newman RA Biomed Pharmacother; 2021 Jun; 138():111457. PubMed ID: 33721754 [TBL] [Abstract][Full Text] [Related]
19. Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways. Li J; Liang X; Yang X Oncol Rep; 2012 Aug; 28(2):501-10. PubMed ID: 22641480 [TBL] [Abstract][Full Text] [Related]
20. The botanical drug PBI-05204, a supercritical CO Vaccaro S; Rossetti A; Porrazzo A; Camero S; Cassandri M; Pomella S; Tomaciello M; Macioce G; Pedini F; Barillari G; Marchese C; Rota R; Cenci G; Tombolini M; Newman RA; Yang P; Codenotti S; Fanzani A; Megiorni F; Festuccia C; Minniti G; Gravina GL; Vulcano F; Milazzo L; Marampon F Front Pharmacol; 2022; 13():1071176. PubMed ID: 36532747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]